T. Rowe Price Investment Management, Inc. Neogenomics Inc Transaction History

T. Rowe Price Investment Management, Inc.

$166 Billion
Q3 2024

A detailed history of T. Rowe Price Investment Management, Inc. transactions in Neogenomics Inc stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 6,541,400 shares of NEO stock, worth $112 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

6,541,400

Previous 6,730,283 2.81%

Holding current value

$112 Million

Previous $93.4 Million 3.36%

% of portfolio

0.06%

Previous 0.06%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$13.4 - $17.73 $2.53 Million - $3.35 Million	-188,883 Reduced 2.81%	6,541,400 $96.5 Million
Q2 2024 Aug 14, 2024	SELL	$13.01 - $15.77 $1.66 Million - $2.01 Million	-127,298 Reduced 1.86%	6,730,283 $93.4 Million
Q1 2024 May 15, 2024	BUY	$14.06 - $16.79 $6.68 Million - $7.98 Million	475,066 Added 7.44%	6,857,581 $108 Million
Q4 2023 Feb 14, 2024	BUY	$11.67 - $20.73 $9.99 Million - $17.8 Million	856,296 Added 15.5%	6,382,515 $103 Million
Q3 2023 Nov 14, 2023	BUY	$12.15 - $17.85 $5.67 Million - $8.33 Million	466,633 Added 9.22%	5,526,219 $68 Million
Q2 2023 Aug 14, 2023	BUY	$14.1 - $19.83 $2.23 Million - $3.14 Million	158,146 Added 3.23%	5,059,586 $81.3 Million
Q1 2023 May 15, 2023	BUY	$9.09 - $19.45 $18 Million - $38.6 Million	1,984,505 Added 68.03%	4,901,440 $85.3 Million
Q4 2022 Feb 14, 2023	BUY	$6.45 - $12.07 $2.24 Million - $4.2 Million	348,026 Added 13.55%	2,916,935 $27 Million
Q3 2022 Nov 14, 2022	BUY	$7.86 - $12.91 $20.2 Million - $33.2 Million	2,568,909 New	2,568,909 $22.1 Million

Others Institutions Holding NEO

# of Institutions

294

Shares Held

124M

Call Options Held

698K

Put Options Held

120K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.16B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of T. Rowe Price Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on T. Rowe Price Investment Management, Inc. with notifications on news.

Account

T. Rowe Price Investment Management, Inc. Neogenomics Inc Transaction History